Drugs / CERVAVAC-4
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07256912 | Apr 2026 → Dec 2028 expected | — | International Agency for Research on Cancer | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CERVAVAC-4 | “CERVAVAC-4 single dose vaccine” NCT07256912 ↗ |
| Modality | Vaccine | “CERVAVAC-4 single dose vaccine” NCT07256912 ↗ |